Enjoy complimentary customisation on priority with our Enterprise License!
The endocrinology drugs market size is forecast to increase by USD 36.84 billion at a CAGR of 7.45% between 2023 and 2028. The market is experiencing significant growth due to the rising incidence of endocrine disorders, particularly diabetes and obesity. The association between obesity and endocrine disorders, such as diabetes and thyroid disorders, is a major driver for the market. Additionally, patent expiry of major endocrinology drugs has led to an increase in competition and price erosion, creating opportunities for generic drug manufacturers. However, challenges such as stringent regulatory requirements and the high cost of research and development continue to pose significant hurdles for market growth. Despite these challenges, the market is expected to witness steady growth due to the increasing prevalence of endocrine disorders and the development of innovative treatments.
Endocrinology is a branch of medicine that deals with the endocrine system, which is responsible for producing hormones in the body. Hormones are essential for various bodily functions, including metabolism, reproduction, and maintaining a healthy balance of fluids and electrolytes. The endocrine system comprises several glands, including the pancreas, thyroid, parathyroid, adrenals, testes, ovaries, pituitary, and hypothalamus. The market includes medications used to treat hormonal imbalances caused by various factors, such as unhealthy lifestyle characteristics, work stress, and chronic diseases like type 2 diabetes. These drugs can be classified into amines, steroids, peptides and proteins. For instance, levothyroxine sodium injection is used to treat hypothyroidism, while teneligliptin and pioglitazone are used to manage type 2 diabetes.
Metformin is another commonly used drug for diabetes treatment. Hormonal imbalances can lead to several health issues, including cholesterol imbalances and weight gain. Endocrinologists play a crucial role in diagnosing and treating these conditions using various hormonal therapies.
The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD billion" for the period 2024-2028, as well as historical data from 2018 - 2022 for the following segments.
The diabetes drugs segment is estimated to witness significant growth during the forecast period. Endocrinology refers to the branch of medicine that deals with the endocrine system, which produces and secretes hormones. Hormones are essential molecules that regulate various bodily functions, including metabolism, reproduction, and growth. The endocrine system comprises several glands, including the pancreas, thyroid, parathyroid, adrenals, testes, ovaries, pituitary, and hypothalamus. Endocrinologists specialize in the diagnosis and treatment of endocrine disorders, such as diabetes mellitus, thyroid disorders, hyperparathyroid disorders, Cushing's syndrome, Addison's disease, pheochromocytoma, and others. The market includes various types of medications, such as amines, steroids, peptides, and proteins. For instance, amines like albuterol are used to treat asthma and other respiratory disorders, while steroids like hydrocortisone are used to reduce inflammation and suppress the immune system.
Peptides and proteins, such as insulin and growth hormone, are used to replace or supplement the natural hormones in the body. Endocrine disorders can lead to several health issues, including osteoporosis, heart disorders, renal disorders, and endocrine diseases. For instance, diabetes mellitus can lead to complications like hypogonadism in men, goiter, thyroiditis, osteomalacia, and gigantism. Endocrinology drugs play a crucial role in managing these disorders and improving patients' quality of life. Vaccines are also used in the treatment of certain endocrine disorders, such as Addison's disease and pheochromocytoma. Overall, the market is expected to grow significantly due to the increasing prevalence of endocrine disorders and the development of new and innovative drugs.
Get a glance at the market share of various segments Request Free Sample
The Diabetes drugs segment accounted for USD 51.01 billion in 2018 and showed a gradual increase during the forecast period.
North America is estimated to contribute 44% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
For more insights on the market share of various regions Request Free Sample
The market is witnessing significant growth due to the rising prevalence of various endocrine disorders, including hyperlipidemia, hypertension, and diabetes. Factors such as hormonal imbalances, and unhealthy lifestyle characteristics like weight gain and work stress, contribute to the increasing incidence of these conditions. For instance, hyperlipidemia, a condition marked by high levels of cholesterol in the blood, is a major risk factor for cardiovascular diseases. Similarly, acromegaly, a hormonal disorder caused by excessive production of growth hormone, and Type 2 diabetes, a metabolic disorder characterized by high blood sugar levels, are also prevalent. The adolescent population is a significant consumer group due to the increasing incidence of thyroid cancer and other endocrine disorders.
Key drugs in the market include Levothyroxine Sodium Injection for thyroid disorders, Teneligliptin, Pioglitazone, and Metformin for diabetes management.
Our endocrinology drugs market researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
An increase in the incidence of endocrine disorders is the key driver of the market. The market is witnessing significant growth due to the increasing prevalence of endocrine disorders, particularly in the aging population. The endocrine system, responsible for producing hormones through various glands such as the pancreas, thyroid, parathyroid, adrenals, testes, ovaries, pituitary, and hypothalamus, plays a crucial role in metabolism, reproduction, and other essential bodily functions. Disorders of these glands, including diabetes mellitus, thyroid disorders, hyperparathyroid disorders, Cushing's syndrome, Addison's disease, pheochromocytoma, and others, pose a significant health concern. Endocrinologists are at the forefront of diagnosing and treating these disorders using various drugs, including amines, steroids, peptides, and proteins. Hormones like insulin, thyroxine, parathyroid hormone, and cortisol are commonly used to manage conditions like osteoporosis, diabetes, heart disorders, renal disorders, and endocrine diseases.
Additionally, vaccines and molecules like hydroxychloroquine are used to treat conditions like hypogonadism in men and various other hormonal imbalances. The increasing burden of endocrine disorders, particularly in low- and middle-income countries, necessitates the development of affordable and effective treatments.
The association between obesity and endocrine disorders is an upcoming trend in the market. Endocrinology refers to the study of the endocrine system, which is responsible for producing, secreting, and regulating various hormones through glands such as the pancreas, thyroid, parathyroid, adrenals, testes, ovaries, pituitary, and hypothalamus. Hormones are essential molecules that regulate metabolism, reproduction, and growth, among other functions. Endocrine disorders, including diabetes mellitus, thyroid disorders, hyperparathyroid disorders, Cushing's syndrome, Addison's disease, pheochromocytoma, and osteoporosis, can be caused by various factors, including genetics, environmental factors, and obesity. Obesity, in turn, can be a manifestation of some endocrine disorders, such as Cushing's syndrome, decreased growth hormone levels, testosterone deficiency, and PCOS. Endocrinologists use various treatments, including steroids, amines, peptides, and proteins, to manage endocrine disorders.
For instance, hydroxychloroquine is used to treat lupus-related kidney disorders, while insulin is used to manage diabetes. Vaccines are also used to prevent certain endocrine disorders, such as thyroiditis and goiter. Endocrine diseases can lead to complications in various organs, including the heart, kidneys, and bones, highlighting the importance of timely diagnosis and treatment. Rare endocrine disorders, such as gigantism and goiter, require specialized treatment and management. Overall, the market is expected to grow due to the increasing prevalence of endocrine disorders and the development of new and innovative treatments.
The patent expiry of major endocrinology drugs is a key challenge affecting the market growth. Endocrinology drugs have been a significant part of the pharmaceutical market since the approval of Wyeth's PREMPRO and PREMPHASE, conjugated estrogens/medroxyprogesterone acetate tablets, for postmenopausal hormone replacement in patients with postmenopausal osteoporosis, in 1995. The endocrine system, responsible for producing hormones through the pancreas, thyroid, parathyroid, adrenals, testes, ovaries, pituitary, and hypothalamus, has been the focus of numerous drug developments. These hormones regulate metabolism, reproduction, and various other functions. Endocrinologists have relied on amines, steroids, peptides, and proteins, in the form of molecules such as insulins, hydroxychloroquine, and vaccines, to treat endocrine disorders like diabetes mellitus, thyroid disorders, hyperparathyroid disorders, Cushing's syndrome, Addison's disease, pheochromocytoma, osteoporosis, and others.
However, many of these blockbuster drugs have faced patent expiry, including Lantus, Humalog, NovoLog/NovoRapid, Humulin, and Novolin. This trend is expected to continue during the forecast period, with several anti-diabetic drugs losing their patents. Other endocrine diseases such as gigantism, goiter, thyroiditis, osteomalacia, and hypogonadism in men are also treated with endocrinology drugs.
The market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
Takeda Pharmaceutical - The company offers endocrinology drugs such as Nesina and Kazano. They generate revenue from focusing on the research, development, manufacturing, and marketing of pharmaceutical products.
The market research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Endocrinology is a branch of medicine that deals with the endocrine system, which is responsible for producing hormones in the body. Hormones are chemical messengers that regulate various functions, including metabolism, reproduction, and growth. The market includes a wide range of medications used to treat disorders of the endocrine system. These drugs can be categorized into amines, steroids, peptides and proteins, and vaccines. The endocrine system comprises several glands, including the pancreas, thyroid, parathyroid, adrenals, testes, ovaries, pituitary, and hypothalamus. Disorders of these glands, such as osteoporosis, diabetes mellitus, thyroid disorders, hyperparathyroid disorders, Cushing's syndrome, Addison's disease, pheochromocytoma, hypogonadism in men, and various other hormonal imbalances, can be treated with endocrinology drugs.
Endocrinologists prescribe these medications to patients suffering from endocrine diseases, such as heart disorders, renal disorders, and gigantism, goiter, thyroiditis, osteomalacia, and other hormonal disorders. Some commonly used endocrinology drugs include hydroxychloroquine, steroids, insulin, and various peptide and protein-based medications. These drugs help regulate hormonal balance and improve patient health.
|
Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
177 |
|
Base year |
2023 |
|
Historic period |
2018-2022 |
|
Forecast period |
2024-2028 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 7.45% |
|
Market growth 2024-2028 |
USD 36.84 billion |
|
Market structure |
Fragmented |
|
YoY growth 2023-2024(%) |
6.8 |
|
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
|
Performing market contribution |
North America at 44% |
|
Key countries |
US, UK, Germany, China, and Canada |
|
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
|
Key companies profiled |
Abbott Laboratories, Acerus Pharmaceuticals Corp., Ascendis Pharma AS, Bayer AG, Beta Cell NV, Biocon Ltd., Eli Lilly and Co., Endo International Plc, F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Hanmi Pharm Co. Ltd., Ipsen Pharma, Merck and Co. Inc., Novartis AG, Novo Nordisk AS, Oramed Pharmaceuticals Inc., Pfizer Inc., Sanofi SA, Takeda Pharmaceutical Co. Ltd., and VeroScience LLC |
|
Market dynamics |
Parent market analysis, market growth inducers and obstacles, market forecast, fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, market condition analysis for the forecast period |
|
Customization purview |
If our market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Therapy Area
7 Market Segmentation by Distribution Channel
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get the report (PDF) sent to your email within minutes.
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
